Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 199

1.

Vitamin D.

Dusso AS, Brown AJ, Slatopolsky E.

Am J Physiol Renal Physiol. 2005 Jul;289(1):F8-28. Review.

2.

The physiology of vitamin D : current concepts.

Kochupillai N.

Indian J Med Res. 2008 Mar;127(3):256-62. Review.

PMID:
18497440
3.

Update on biological actions of 1alpha,25(OH)2-vitamin D3 (rapid effects) and 24R,25(OH)2-vitamin D3.

Norman AW, Okamura WH, Bishop JE, Henry HL.

Mol Cell Endocrinol. 2002 Nov 29;197(1-2):1-13. Review.

PMID:
12431790
4.
5.

The vitamin D hormone and its nuclear receptor: molecular actions and disease states.

Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK.

J Endocrinol. 1997 Sep;154 Suppl:S57-73. Review.

6.

In vivo function of VDR in gene expression-VDR knock-out mice.

Kato S, Takeyama K, Kitanaka S, Murayama A, Sekine K, Yoshizawa T.

J Steroid Biochem Mol Biol. 1999 Apr-Jun;69(1-6):247-51. Review.

PMID:
10418998
8.

Vitamin D.

Brown AJ, Dusso A, Slatopolsky E.

Am J Physiol. 1999 Aug;277(2 Pt 2):F157-75. Review.

9.

The vitamin D receptor.

Carlberg C, Seuter S.

Dermatol Clin. 2007 Oct;25(4):515-23, viii. Review.

PMID:
17903610
10.

Mechanism of vitamin D action and its regulation.

Dusso AS, Brown AJ.

Am J Kidney Dis. 1998 Oct;32(2 Suppl 2):S13-24. Review.

PMID:
9808140
11.

[Regulation of gene expression and vitamin].

Takeda E, Yamamoto H, Miyamoto K.

Nihon Rinsho. 1999 Oct;57(10):2295-300. Review. Japanese.

PMID:
10540876
12.

Vitamin D and systemic cancer: is this relevant to malignant melanoma?

Osborne JE, Hutchinson PE.

Br J Dermatol. 2002 Aug;147(2):197-213. Review.

PMID:
12174089
13.
14.

Vitamin D resistance.

Bouillon R, Verstuyf A, Mathieu C, Van Cromphaut S, Masuyama R, Dehaes P, Carmeliet G.

Best Pract Res Clin Endocrinol Metab. 2006 Dec;20(4):627-45. Review.

PMID:
17161336
15.

The immunological functions of the vitamin D endocrine system.

Hayes CE, Nashold FE, Spach KM, Pedersen LB.

Cell Mol Biol (Noisy-le-grand). 2003 Mar;49(2):277-300. Review.

PMID:
12887108
16.

Molecular tools for study of genomic and rapid signal transduction responses initiated by 1 alpha,25(OH)(2)-vitamin D(3).

Norman AW, Bishop JE, Bula CM, Olivera CJ, Mizwicki MT, Zanello LP, Ishida H, Okamura WH.

Steroids. 2002 May;67(6):457-66. Review.

PMID:
11960621
17.

Carboxylic ester antagonists of 1alpha,25-dihydroxyvitamin D(3) show cell-specific actions.

Herdick M, Steinmeyer A, Carlberg C.

Chem Biol. 2000 Nov;7(11):885-94.

18.

Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts.

Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G.

J Clin Invest. 2006 Dec;116(12):3150-9. Epub 2006 Nov 9.

19.

Vitamin D receptor as a drug discovery target.

Pinette KV, Yee YK, Amegadzie BY, Nagpal S.

Mini Rev Med Chem. 2003 May;3(3):193-204. Review.

PMID:
12570835
20.

Vitamin D nutritional policy needs a vision for the future.

Norman AW, Bouillon R.

Exp Biol Med (Maywood). 2010 Sep;235(9):1034-45. doi: 10.1258/ebm.2010.010014. Epub 2010 Jul 28. Review.

PMID:
20667908

Supplemental Content

Support Center